Zealand Pharma A/S (ZLDPF)
51.80
+3.56
(+7.39%)
USD |
OTCM |
Aug 25, 16:00
Zealand Pharma Gross Profit Margin (Quarterly) : 99.76% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 99.76% |
| March 31, 2026 | 70.59% |
| December 31, 2025 | 88.42% |
| September 30, 2025 | 85.43% |
| June 30, 2025 | 99.93% |
| March 31, 2025 | 21.36% |
| December 31, 2024 | 26.21% |
| September 30, 2024 | |
| June 30, 2024 | 52.38% |
| March 31, 2024 | 25.67% |
| December 31, 2023 | 39.69% |
| September 30, 2023 | 98.25% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 98.68% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 9.38% |
| September 30, 2021 | |
| June 30, 2021 | 68.05% |
| March 31, 2021 | |
| December 31, 2020 | 28.35% |
| September 30, 2020 | 5.05% |
| June 30, 2020 | 87.32% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 97.67% |
| June 30, 2019 | 99.08% |
| March 31, 2019 | |
| December 31, 2018 | 0.00% |
| September 30, 2018 | |
| June 30, 2018 | 86.50% |
| March 31, 2018 | 86.49% |
| December 31, 2017 | 86.50% |
| September 30, 2017 | 96.78% |
| June 30, 2017 | 88.75% |
| March 31, 2017 | 86.50% |
| December 31, 2016 | 85.80% |
| September 30, 2016 | 86.54% |
| June 30, 2016 | 89.22% |
| March 31, 2016 | 86.54% |
| December 31, 2015 | 87.35% |
| September 30, 2015 | 65.26% |
| June 30, 2015 | 65.32% |
| March 31, 2015 | 62.14% |
| December 31, 2014 | 60.11% |
| September 30, 2014 | 96.24% |
| June 30, 2014 | 53.12% |
| March 31, 2014 | 84.71% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Genmab A/S | 92.73% |
| Ascendis Pharma A/S | 90.64% |
| Bavarian Nordic A/S | 60.45% |
| Evaxion AS | -- |
| Novo Nordisk A/S | 78.21% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.49% |
| Return on Assets | 15.97% |
| Return on Invested Capital | 17.05% |
| Profit Margin (Quarterly) | 87.22% |
| Operating Margin (Quarterly) | 85.93% |
| Return on Net Operating Assets | 187.9% |